🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is intended to test efficacy, safety and tolerability of two dose...
Status
Completed
Location
Site: 12
Start Date
2004-04-05
Trial ID
NCT01604928
Treatments Being Tested
The objective of this study is to determine the effect of multiple doses of...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT01297179
Treatments Being Tested
The purpose of this study was to examine how well the combination of two me...
Status
Completed
Location
Site US10049
Start Date
2014-03-17
Trial ID
NCT02045862
Treatments Being Tested
Objective: The objective of the study is to assess the structural and funct...
Status
Completed
Location
Rigshospitalet
Start Date
2017-01-23
Trial ID
NCT03926754
Treatments Being Tested
The purpose of this study was to see if adding a new type of medication rec...
Status
Completed
Location
Genova Clinical Research
Start Date
2013-07-10
Trial ID
NCT01908829
The study is intended to test the efficacy, safety and tolerability of two ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-28
Trial ID
NCT00662909
Treatments Being Tested
The purpose of this research study is to determine the effectiveness and sa...
Status
Unknown
Location
Kessler Institute for Rehabilitation
Start Date
2019-04-03
Trial ID
NCT03187795
Treatments Being Tested
This study evaluates whether a medication called mirabegron is better than ...
Status
Terminated
Location
Thomas Jefferson University
Start Date
2018-02-15
Trial ID
NCT03411252
Treatments Being Tested
The purpose of this study is to see if the study drug, Mirabegron, is safe ...
Status
Completed
Location
Evergreenhealth Booth Gardner Parkinsons Care Center
Start Date
2014-03
Trial ID
NCT02092181
Treatments Being Tested
Women presenting with overactive bladder symptoms will be randomized to one...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2019-08-05
Trial ID
NCT03817931